Gilde healthcare sells LAVA Therapeutics (LVTX) shares for $4.2m
PositiveFinancial Markets

Gilde Healthcare has successfully sold its shares in LAVA Therapeutics for $4.2 million, marking a significant financial move in the healthcare sector. This sale not only reflects Gilde's strategic investment decisions but also highlights the growing interest in innovative therapeutic solutions. The transaction is expected to bolster Gilde's portfolio and provide them with additional resources to invest in future healthcare ventures.
— Curated by the World Pulse Now AI Editorial System